Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome

Table 4 Number of types of major adverse cardiac events during the follow-up period

Event	Total	Within 1 wk	1 wk to 1 month	1-6 months	6-12 months	After 12 months
Cardiac death	13	2	4	4	1	2
Other death	4	2	0	1	0	1
Nonfatal STEMI	2	1	0	0	0	1
Unstable angina	5	0	0	3	0	2
TLR or new PCI	102	0	5	42	36	19
New lesion with ischemia	9	0	1	2	1	5
Nonfatal stroke	7	1	0	1	1	4
EVT for PAD	2	0	0	0	2	0

EVT: Endovascular therapy; PAD: Peripheral artery disease; PCI: Percutaneous coronary intervention; STEMI: ST elevation myocardial infarction; TLR: Target lesion revascularization.